AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Hepatitis Weekly back issues
|
|
Good news for some hard-to-treat hepatitis C patients.
June 29, 2009... In a multi-center trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment. The findings, published in the June issue of...
Research on acute hepatitis detailed by H. Peyriere and co-authors.
June 29, 2009... "To report 2 cases of acute hepatitis related to intravenous administration of buprenorphine in hepatitis C-infected patients. SUMMARY: Two patients, aged 33 and 50 years, respectively, who were hepatitis C virus (HCV) carriers were treated with sublingual buprenorphine 8 mg/day for...
Research reports from V. Traksmayra and co-authors provide new insights into alcoholism.
June 29, 2009... According to recent research from Clichy, France, "Chronic liver diseases, including cirrhosis, may develop in obese patients. Steatosis and non-alcoholic steatohepatitis (NASH) are risk factors for progression to fibrosis."
"To date, diagnosis of steatosis and NASH relies on liver...
Reports summarize erythema research from E. Lazaridou and co-authors.
June 29, 2009... "Erythema nodosum migrans (ENM) is believed to represent a variant of chronic erythema nodosum; however, others consider it to be a separate clinical entity. It most commonly affects women in the third to sixth decade of life," scientists in Thessaloniki, Greece report (see also Erythema)....
Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures.
June 29, 2009... Three Rivers Pharmaceuticals announced positive results of the U.S.-based, randomized Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy (DIRECT) clinical trial authored by Bruce R. Bacon, M.D., of Saint Louis University, and colleagues at 44 centers in the United...